Thistle Mary
SEC-identified person · CIK 1317917 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Cullinan Therapeutics, Inc. CGEM | Director | filed 2024–2026 |
| Q32 Bio Inc. QTTB | Director | filed 2018–2026 |
| Entrada Therapeutics, Inc. TRDA | Director | filed 2021–2026 |
| Aktis Oncology, Inc. AKTS | Director | filed 2026–2026 |
| Vigil Neuroscience, Inc. VIGL | Director | filed 2022–2025 |
| Ziopharm Oncology INC ZIOP | Director | filed 2020–2023 |
| Dimension Therapeutics, Inc. DMTX | Chief Operating Officer | filed 2015–2017 |
| Viacell INC VIAC | Sr VP & GM Reproductive Health | filed 2006–2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.